Comment: The chemical structure for elunonavir was obtained from WHO Proposed list 125. The IUPAC>SMILES conversion maps to PubChem CID 135301900. Via SureChEMBL we can trace this compound to a Gilead Sciences patent that claims antiviral compounds for the treatment of HIV [ 1]. From the patent it would appear that elunonavir is an HIV protease inhibitor.
|
|
2D Structure
|
|
Physico-chemical Properties
|
|
Hydrogen bond acceptors
|
18
|
Hydrogen bond donors
|
5
|
Rotatable bonds
|
27
|
Topological polar surface area
|
217.64
|
Molecular weight
|
1155.44
|
XLogP
|
8.47
|
No. Lipinski's rules broken
|
3
|
Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
|
SMILES / InChI / InChIKey
|
|
Canonical SMILES
|
COC(=O)N[C@@H](C(C(F)(F)F)(C)C)C(=O)N[C@H]([C@H](CN(Cc1c(F)cc(cc1F)c1ccn(n1)C(F)F)NC(=O)[C@H](C(C(F)(F)F)(C)C)NC(=O)OC)O)Cc1ccc(cc1)C#Cc1cnc(nc1)N1CC2CCC(C1)N2C1COC1
|
Isomeric SMILES
|
CC(C)([C@@H](C(=O)N[C@@H](Cc1ccc(cc1)C#Cc1cnc(nc1)N1CC2CCC(C1)N2C1COC1)[C@H](CN(Cc1c(cc(cc1F)c1nn(cc1)C(F)F)F)NC(=O)[C@H](C(C)(C)C(F)(F)F)NC(=O)OC)O)NC(=O)OC)C(F)(F)F
|
InChI
|
InChI=1S/C52H59F10N11O8/c1-49(2,51(57,58)59)41(66-47(77)79-5)43(75)65-39(17-29-10-7-28(8-11-29)9-12-30-20-63-46(64-21-30)70-22-32-13-14-33(23-70)73(32)34-26-81-27-34)40(74)25-71(69-44(76)42(67-48(78)80-6)50(3,4)52(60,61)62)24-35-36(53)18-31(19-37(35)54)38-15-16-72(68-38)45(55)56/h7-8,10-11,15-16,18-21,32-34,39-42,45,74H,13-14,17,22-27H2,1-6H3,(H,65,75)(H,66,77)(H,67,78)(H,69,76)/t32?,33?,39-,40-,41+,42+/m0/s1
|
InChI Key
|
ZTSLYWLHCOINNI-FTEFBJIISA-N
|
Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)
|
|